- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02599766
Effects of Animal-assisted Therapy on Brain-injured Patients
Short-term Effects of Animal-assisted Therapy on the Rehabilitation Process of Brain-injured Patients at REHAB Basel
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is designed as a controlled cross-over, within-subject trial with repeated measurement. The experimental condition is the standardised therapy session using therapy animals (AAT), while the control condition is the comparable "standard" therapy session without the presence of an animal.
Over a period of six weeks, patients have four standardised therapy sessions per week, that alternate in a way that two sessions in two consecutive weeks are similar except for one is with the presence of animals and one without. In this way, data is collected over 24 therapy sessions (12 experimental, 12 control) for each patient.
Each therapy session lasts 30 minutes with an additional 5 minutes before and 10 minutes after the session for filling in the questionnaires.
The study takes place at REHAB Basel. Animal-assisted therapies will be held at the "Therapie-Tiergarten" at REHAB Basel in the presence of one or more animals that will be selected by the therapist and the patient together and with which the patient has a relationship.
Patients who are willing to join the study will be selected and allocated randomly to start with either the experimental or the control condition.
Participation in the study will be cancelled if a patient wishes to do so or if they choose to withdraw from the animal-assisted therapy program. Other criteria for withdrawal are if the patient is harmed by an animal or if the animals are abused by the patient.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Basel, Switzerland, 4012
- REHAB Basel
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patient at REHAB Basel
- brain-injury
- willing to participate in animal-assisted therapies
- physical and psychological resilience and ability to go/be transported outside to the "Therapie-Tiergarten"
- ability to get in contact with the animal autonomously
Exclusion Criteria:
- medical contraindications:allergies, phobias, etc.
- no willingness to participate in animal-assisted therapies
- patient might present a danger to the animals (aggressive behaviour)
- patient's medication changes radically during the time of data collection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: animal assisted therapy
"Standard therapy" that is done in the presence and with integrating an animal.
|
physiotherapy, speech therapy and occupational therapy in the presence of an animal
|
Active Comparator: standard therapy
"Standard therapy" without the presence of an animal.
|
standard physiotherapy, standard speech therapy and standard occupational therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Functioning: Total Social Behavior
Time Frame: 6 weeks
|
Interaction and communication behavior is assessed via video coding in Noldus Observer.
Percentage of all social behaviors are collected and aggregated to one measure, the total social behavior.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Functioning: Verbal Communication
Time Frame: 6 weeks
|
Interaction and communication behavior is assessed via video coding in Noldus Observer.
Percentages of the defined verbal behaviors is collected and aggregated to one measure.
|
6 weeks
|
Social Functioning: Nonverbal Communication
Time Frame: 6 weeks
|
Interaction and communication behavior is assessed via video coding in Noldus Observer.
Percentage of the defined nonverbal behaviors is collected and aggregated to one measure.
|
6 weeks
|
Social Functioning: Physical Contact
Time Frame: 6 weeks
|
Interaction and communication behavior is assessed via video coding in Noldus Observer.
Percentage of the defined physical contact is collected and aggregated to one measure.
|
6 weeks
|
Social Functioning: Attention
Time Frame: 6 weeks
|
Interaction and communication behavior is assessed via video coding in Noldus Observer.
Percentage of the defined attention behavior is collected and aggregated to one measure.
|
6 weeks
|
Positive Emotional Display
Time Frame: 6 weeks
|
Emotional display is assessed via video coding in Noldus Observer.
Percentage of the defined behavior during the therapy sessions is collected and aggregated to one measure of positive emotion.
|
6 weeks
|
Negative Emotional Display
Time Frame: 6 weeks
|
Emotional display is assessed via video coding in Noldus Observer.
Percentage of the defined behavior during the therapy sessions is collected and aggregated to one measure of negative emotion.
|
6 weeks
|
Neutral Emotional Display
Time Frame: 6 weeks
|
Emotional display is assessed via video coding in Noldus Observer.
Percentage of the defined behavior during the therapy sessions is collected and aggregated to one measure of neutral emotion.
|
6 weeks
|
Mood 1: Motivation
Time Frame: 6 weeks
|
Assessed via visual analogue scale as self-rating Scale ranging from 0 (not motivated) to 160 (highly motivated)
|
6 weeks
|
Mood 2: Bipolar Mood Dimension (Good-bad)
Time Frame: 6 weeks
|
Assessed via the Mehrdimensionaler Befindlichkeitsfragebogen (MDBF) We analysed the bipolar mood dimension (good-bad) ranging from 4 (not at all good mood) to 20 (very good mood).
|
6 weeks
|
Mood 3: Satisfaction Self-assessment
Time Frame: 6 weeks
|
Assessed via visual analogue scale as rating by the therapist Satisfaction during the therapy sessions was assessed by the patient themselves using a VAS ranging from 0 (unsatisfied) to 160 (satisfied).
|
6 weeks
|
Mood 4: Satisfaction Therapist Rating
Time Frame: 6 weeks
|
Satisfaction during the therapy sessions was assessed by the therapist using a VAS ranging from 0 (unsatisfied) to 160 (satisfied).
|
6 weeks
|
Heart Rate
Time Frame: 6 weeks
|
Assessed via EKG (Polar) during the sessions and measured in beat/min.
|
6 weeks
|
Motor Activity
Time Frame: 6 weeks
|
Assessed via actimeter at the patients wrist during sessions, measuring acceleration of the hand.
It records data in 15-s epochs for maximum sensitivity.
Data were calculated to yield average activity Counts per minute.
|
6 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Margret Hund-Georgiadis, PD Dr., REHAB Basel
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Ref.Nr.EK:296/13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Impaired Social Functioning
-
Koç UniversityRecruitingDepressive Symptoms | Psychological Distress | Impaired Social FunctioningTurkey
-
Seattle Children's HospitalUniversity of Pittsburgh Medical CenterNot yet recruitingCancer | Coping Skills | Psychosocial Functioning | Social Functioning
-
University of TorontoRecruitingSocial Skills | Financial Stress | Social FunctioningUganda
-
University of Illinois at ChicagoNational Institute of Mental Health (NIMH)Not yet recruitingDepression | PTSD | Anxiety | Family Dynamics | Social Functioning
-
University of CatanzaroRecruitingVascular Diseases | Psychosocial Problem | Social FunctioningItaly
-
Barcelona Institute for Global HealthRecercaixa; Centre de Recerca per a l'Educació Científica i Matemàtica (CRECIM) and other collaboratorsCompletedRisk Behavior | Attention Impaired | Risk-Taking | Social Preferences | Decision Making | AttentionSpain
-
Jagiellonian UniversityInstitute of Environmental Protection - National Research Institute (IOS-PIB) and other collaboratorsNot yet recruitingAttention Deficit Hyperactivity Disorder | Attention | Executive Functioning | Social FunctioningPoland
-
Bartosz M. RadtkeRecruitingNeurodevelopmental Disorders | Child Development | Adolescent Development | Social Functioning | Perinatal ConditionPoland
-
Salem Anaesthesia Pain ClinicRecruitingChronic Pain | Injuries | Disabilities Multiple | Social FunctioningCanada
-
Duke UniversityCompletedAging | Cognitive Functioning | Fitness | Physical FunctioningUnited States
Clinical Trials on animal assisted therapy
-
Atlas UniversityNot yet recruitingDepression | Loneliness | Old Age; Debility | Nursing Home | Loss of Interest in Activities
-
Norwegian University of Life SciencesCompleted
-
Daniel Collado-MateoAsociación Dame La PataRecruitingWork Related Stress | Occupational GroupsSpain
-
Daniel Collado-MateoPurina España (Reg. Trademark of Nestle S.A.)Enrolling by invitationEating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/BulimiaSpain
-
Daniel Collado-MateoAsociación de Padres de Personas Con Autismo (APNA); Asociación Nuevo Horizonte and other collaboratorsEnrolling by invitationAutism Spectrum Disorder | AutismSpain
-
Uskudar UniversityNot yet recruiting
-
Chang Gung Memorial HospitalUnknownSchizophrenia | Animal-assisted TherapyTaiwan
-
Mayo ClinicCompletedHospitalized PatientsUnited States
-
Fundacio d'Investigacio en Atencio Primaria Jordi...CompletedChronic Pain
-
IRCCS Policlinico S. MatteoCompleted